Top

Published in:

01-07-2009 | Original Article

Association between migraine and a functional polymorphism at the dopamine β-hydroxylase locus

Authors: F. Fernandez, N. Colson, S. Quinlan, J. MacMillan, R. A. Lea, L. R. Griffiths

Published in: Neurogenetics | Issue 3/2009

Abstract

Migraine is a common neurological disorder with a significant genetic component. Although a number of linkage and association studies have been undertaken, the number and identity of all migraine susceptibility genes has yet to be defined. The existence of dopaminergic hypersensitivity in migraine has been recognised on a pharmacological basis and some studies have reported genetic association between migraine and dopamine-related gene variants. Our laboratory has previously reported association of migraine with a promoter STR marker in the dopamine beta hydroxylase (DBH) gene. In the present study, we analysed two additional DBH markers in two independent migraine case–control cohorts. These two markers are putative functional SNPs, one within the promoter (−1021C→T) and another SNP (+1603C→T) in exon 11 of the DBH gene. The results showed a significant association for allelic and genotypic frequency distribution between the DBH marker in the promoter and migraine in the first (P = 0.004 and P = 0.012, respectively) and the second (P = 0.013 and P = 0.031, respectively) tested cohorts. There was no association observed between either genotype and/or allelic frequencies for the DBH marker located in exon 11 and migraine (P ≥ 0.05). The promoter DBH marker, reported associated with migraine in this study, has been shown to affect up to 52% of plasma DBH activity. Varying DBH activity levels have been postulated to be involved in migraine process with an increase of dopamine, resulting from a lower DBH activity shown positively correlated with migraine severity. It is plausible that the functional promoter variant of DBH may play a role in the migraine disorder.

Abecasis GR, Cookson WO (2000) GOLD–graphical overview of linkage disequilibrium. Bioinformatics 16:182–183. doi:10.1093/bioinformatics/16.2.182 PubMedCrossRef

Anthony M (1981) Biochemical indices of sympathetic activity in migraine. Cephalalgia 1:83–89. doi:10.1111/j.1468-2982.1981.tb00014.x PubMedCrossRef

Barbanti P, Fabbrini G, Ricci A, Bruno G, Cerbo R, Bronzetti E, Amenta F, Luigi Lenzi G (2000) Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer’s disease. Mech Ageing Dev 120:65–75. doi:10.1016/S0047-6374(00)00183-4 PubMedCrossRef

Castillo J, Martinez F, Suarez C, Naveiro J, Lema M, Noya M (1996) Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients. Cephalalgia 16:56–61. doi:10.1046/j.1468-2982.1996.1601056.x PubMedCrossRef

Cerbo R, Barbanti P, Buzzi MG, Fabbrini G, Brusa L, Roberti C, Zanette E, Lenzi GL (1997) Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol 20:36–41. doi:10.1097/00002826-199702000-00004 PubMedCrossRef

Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J (2000) A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5:56–63. doi:10.1038/sj.mp.4000657 PubMedCrossRef

Cubells JF, Price LH, Meyers BS, Anderson GM, Zabetian CP, Alexopoulos GS, Nelson JC, Sanacora G, Kirwin P, Carpenter L, Malison RT, Gelernter J (2002) Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry 51:358–364. doi:10.1016/S0006-3223(01)01349-X PubMedCrossRef

Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O’Connor DT, Price LH, Malison R, Rao PA, Kobayashi K, Nagatsu T, Gelernter J (1998) Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 102:533–540. doi:10.1007/s004390050736 PubMedCrossRef

Cubells JF, Zabetian CP (2004) Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 174:463–476. doi:10.1007/s00213-004-1840-8 CrossRef

10.

D’Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G (2006) Platelet levels of dopamine are increased in migraine and cluster headache. Headache 46:585–591. doi:10.1111/j.1526-4610.2006.00407.x PubMedCrossRef

11.

Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP (1998) Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51:781–786PubMed

12.

Depondt C, Cock HR, Healy DG, Burley MW, Weinshenker D, Wood NW, Goldstein DB, Sisodiya SM (2004) The -1021C->T DBH gene variant is not associated with epilepsy or antiepileptic drug response. Neurology 63:1497–1499PubMed

13.

Dobrowolski SF, Ellingson C, Coyne T, Grey J, Martin R, Naylor EW, Koch R, Levy HL (2007) Mutations in the phenylalanine hydroxylase gene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyping based upon thermal melt profiles. Mol Genet Metab 91:218–227. doi:10.1016/j.ymgme.2007.03.010 PubMedCrossRef

14.

Fanciullacci M, Alessandri M, Del Rosso A (2000) Dopamine involvement in the migraine attack. Funct Neurol 15(Suppl 3):171–181PubMed

15.

Fernandez F, Lea RA, Colson NJ, Bellis C, Quinlan S, Griffiths LR (2006) Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci 251:118–123. doi:10.1016/j.jns.2006.09.013 PubMedCrossRef

16.

Fisher H (1997) Migraine research methods. CMAJ 157:1015–1016, 1018PubMed

17.

Friberg L, Olesen J, Iversen HK, Sperling B (1991) Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 338:13–17. doi:10.1016/0140-6736(91)90005-A PubMedCrossRef

18.

Gallai V, Gaiti A, Sarchielli P, Coata G, Trequattrini A, Paciaroni M (1992) Evidence for an altered dopamine beta-hydroxylase activity in migraine and tension-type headache. Acta Neurol Scand 86:403–406PubMedCrossRef

19.

Gervil M, Ulrich V, Olesen J, Russell MB (1998) Screening for migraine in the general population: validation of a simple questionnaire. Cephalalgia 18:342–348. doi:10.1046/j.1468-2982.1998.1806342.x PubMedCrossRef

20.

Gotoh F, Kanda T, Sakai F, Yamamoto M, Takeoka T (1976) Serum dopamine-beta-hydroxylase activity in migraine. Arch Neurol 33:656–657PubMed

21.

HCCIHS (2004) Headache Classification Committee for the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. 2nd edn. Cephalgia 24(Suppl 1):1–60

22.

Healy DG, Abou-Sleiman PM, Ozawa T, Lees AJ, Bhatia K, Ahmadi KR, Wullner U, Berciano J, Moller JC, Kamm C, Burk K, Barone P, Tolosa E, Quinn N, Goldstein DB, Wood NW (2004) A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson’s disease. Ann Neurol 55:443–446. doi:10.1002/ana.20063 PubMedCrossRef

23.

Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S (2006) Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Headache 46:781–787. doi:10.1111/j.1526-4610.2006.00438.x PubMedCrossRef

24.

Kirchmann M, Seven E, Bjornsson A, Bjornssdottir G, Gulcher JR, Stefansson K, Olesen J (2006) Validation of the deCODE Migraine Questionnaire (DMQ3) for use in genetic studies. Eur J Neurol 13:1239–1244. doi:10.1111/j.1468-1331.2006.01491.x PubMedCrossRef

25.

Krypuy M, Ahmed AA, Etemadmoghadam D, Hyland SJ, DeFazio A, Fox SB, Brenton JD, Bowtell DD, Dobrovic A (2007) High resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer 7:168. doi:10.1186/1471-2407-7-168 PubMedCrossRef

26.

Launer LJ, Terwindt GM, Ferrari MD (1999) The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 53:537–542PubMed

27.

Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR (2000) Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 3:35–40PubMed

28.

Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343–349. doi:doi:10.1212/01.wnl.0000252808.97649.21 PubMedCrossRef

29.

Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W (2003) A self-administered screener for migraine in primary care: the ID migraine validation study. Neurology 61:375–382PubMed

30.

Lipton RB, Stewart WF (1993) Migraine in the United States: a review of epidemiology and health care use. Neurology 43:S6–S10PubMed

31.

Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M (1993) Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 13:89–93. doi:10.1046/j.1468-2982.1993.1302089.x PubMedCrossRef

32.

Mikamo K, Takeshima T, Takahashi K (1989) Cardiovascular sympathetic hypofunction in muscle contraction headache and migraine. Headache 29:86–89. doi:10.1111/j.1526-4610.1989.hed2902086.x PubMedCrossRef

33.

Mochi M, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Scapoli C, Montagna P (2003) A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci 23:301–305. doi:10.1007/s100720300005 PubMedCrossRef

34.

Nahmias J, Burley MW, Povey S, Porter C, Craig I, Wolfe J (1992) A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase locus. Hum Mol Genet 1:286. doi:10.1093/hmg/1.4.286 PubMedCrossRef

35.

O’Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE, Madrazo I, Langlais PJ, Robertson D, Biaggioni I (1994) Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson’s disease and congenital dopamine beta-hydroxylase deficiency. Clin Sci (Lond) 86:149–158

36.

O’Connor TP, van der Kooy D (1988) Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci 8:2468–2476PubMed

37.

Pasay C, Arlian L, Morgan M, Vyszenski-Moher D, Rose A, Holt D, Walton S, McCarthy J (2008) High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med Vet Entomol 22:82–88. doi:10.1111/j.1365-2915.2008.00716.x PubMedCrossRef

38.

Peroutka SJ (1997) Dopamine and migraine. Neurology 49:650–656PubMed

39.

Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44:53–64. doi:10.1111/j.1526-4610.2004.04011.x PubMedCrossRef

40.

Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49:201–206PubMed

41.

Pradalier A, Launay JM, Soliman M, Dreux C, Guittard M, Hanna KM, Dry J (1987) Platelet release of dopamine in the common migraine attack. Presse Med 16:1321–1323PubMed

42.

Rasmussen BK, Jensen R, Olesen J (1991) Questionnaire versus clinical interview in the diagnosis of headache. Headache 31:290–295. doi:10.1111/j.1526-4610.1991.hed3105290.x PubMedCrossRef

43.

Russell MB, Ulrich V, Gervil M, Olesen J (2002) Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache 42:332–336. doi:10.1046/j.1526-4610.2002.02102.x PubMedCrossRef

44.

Sanger GJ, Andrews PL (2006) Treatment of nausea and vomiting: gaps in our knowledge. Auton Neurosci 129:3–16. doi:10.1016/j.autneu.2006.07.009 PubMedCrossRef

45.

Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R, Quigley EM (1995) Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation. Lancet 346:861–864. doi:10.1016/S0140-6736(95)92707-7 PubMedCrossRef

46.

Siva A, Zarifoglu M, Ertas M, Saip S, Karli HN, Baykan B, Keskinaslan A, Senocak M (2008) Validity of the ID-migraine screener in the workplace. Neurology 70:1337–1345. doi:10.1212/01.wnl.0000309221.85545.0d PubMedCrossRef

47.

Suzuki N, Hardebo JE (1993) The cerebrovascular parasympathetic innervation. Cerebrovasc Brain Metab Rev 5:33–46PubMed

48.

Takeshima T, Takao Y, Urakami K, Nishikawa S, Takahashi K (1989) Muscle contraction headache and migraine. Platelet activation and plasma norepinephrine during the cold pressor test. Cephalalgia 9:7–13. doi:10.1046/j.1468-2982.1989.0901007.x PubMedCrossRef

49.

Tang Y, Anderson GM, Zabetian CP, Kohnke MD, Cubells JF (2005) Haplotype-controlled analysis of the association of a non-synonymous single nucleotide polymorphism at DBH (+ 1603C –> T) with plasma dopamine beta-hydroxylase activity. Am J Med Genet B Neuropsychiatr Genet 139:88–90. doi:10.1002/ajmg.b.30220

50.

Tang YL, Epstein MP, Anderson GM, Zabetian CP, Cubells JF (2007) Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans. Eur J Hum Genet 15:878–883. doi:10.1038/sj.ejhg.5201838 PubMedCrossRef

51.

Wei J, Ramchand CN, Hemmings GP (1997) Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals. Hum Genet 99:52–55. doi:10.1007/s004390050310 PubMedCrossRef

52.

Weinshilboum RM (1978) Serum dopamine beta-hydroxylase. Pharmacol Rev 30:133–166PubMed

53.

Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS, Kim CH, Malison RT, Gelernter J, Cubells JF (2001) A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68:515–522. doi:10.1086/318198 PubMedCrossRef

54.

Zabetian CP, Buxbaum SG, Elston RC, Kohnke MD, Anderson GM, Gelernter J, Cubells JF (2003) The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet 72:1389–1400. doi:10.1086/375499 PubMedCrossRef

Title: Association between migraine and a functional polymorphism at the dopamine β-hydroxylase locus
Authors: F. Fernandez
N. Colson
S. Quinlan
J. MacMillan
R. A. Lea
L. R. Griffiths
Publication date: 01-07-2009
Publisher: Springer-Verlag
Published in: Neurogenetics / Issue 3/2009
Print ISSN: 1364-6745
Electronic ISSN: 1364-6753
DOI: https://doi.org/10.1007/s10048-009-0176-2

At a glance: The STEP trials

Springer Medicine

Association between migraine and a functional polymorphism at the dopamine β-hydroxylase locus

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2009

Examination of association of genes in the serotonin system to autism

Familial hemiplegic migraine: linkage to chromosome 14q32 in a Spanish kindred

A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype

Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes

A new complex homozygous large rearrangement of the PINK1 gene in a Sudanese family with early onset Parkinson’s disease

Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer’s disease